LIANY
Price
$0.43
Change
+$0.01 (+2.38%)
Updated
Jul 3 closing price
Capitalization
47.28M
37 days until earnings call
SER
Price
$5.94
Change
-$0.20 (-3.26%)
Updated
Jul 3 closing price
Capitalization
59.21M
Interact to see
Advertisement

LIANY vs SER

Header iconLIANY vs SER Comparison
Open Charts LIANY vs SERBanner chart's image
LianBio
Price$0.43
Change+$0.01 (+2.38%)
Volume$4.09K
Capitalization47.28M
Serina Therapeutics
Price$5.94
Change-$0.20 (-3.26%)
Volume$1.15K
Capitalization59.21M
LIANY vs SER Comparison Chart in %
Loading...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIANY vs. SER commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIANY is a Buy and SER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (LIANY: $0.43 vs. SER: $5.94)
Brand notoriety: LIANY and SER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIANY: 2% vs. SER: 9%
Market capitalization -- LIANY: $47.28M vs. SER: $59.21M
LIANY [@Biotechnology] is valued at $47.28M. SER’s [@Biotechnology] market capitalization is $59.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIANY’s FA Score shows that 1 FA rating(s) are green whileSER’s FA Score has 0 green FA rating(s).

  • LIANY’s FA Score: 1 green, 4 red.
  • SER’s FA Score: 0 green, 5 red.
According to our system of comparison, LIANY is a better buy in the long-term than SER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIANY’s TA Score shows that 4 TA indicator(s) are bullish while SER’s TA Score has 6 bullish TA indicator(s).

  • LIANY’s TA Score: 4 bullish, 4 bearish.
  • SER’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SER is a better buy in the short-term than LIANY.

Price Growth

LIANY (@Biotechnology) experienced а +6.93% price change this week, while SER (@Biotechnology) price change was -3.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

LIANY is expected to report earnings on Aug 12, 2025.

SER is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SER($59.2M) has a higher market cap than LIANY($47.3M). LIANY YTD gains are higher at: 63.509 vs. SER (18.563). SER has higher annual earnings (EBITDA): -488K vs. LIANY (-105.26M). SER has less debt than LIANY: SER (227K) vs LIANY (2.84M). LIANY (0) and SER (0) have equivalent revenues.
LIANYSERLIANY / SER
Capitalization47.3M59.2M80%
EBITDA-105.26M-488K21,569%
Gain YTD63.50918.563342%
P/E RatioN/A1.76-
Revenue00-
Total CashN/A4.27M-
Total Debt2.84M227K1,252%
FUNDAMENTALS RATINGS
SER: Fundamental Ratings
SER
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LIANYSER
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNLRF0.110.02
+22.37%
PT Unilever Indonesia Tbk
ENDGF0.180.01
+8.26%
Endurance Gold Corp.
SLCJY3.520.02
+0.43%
SLC Agricola Sa
CDAB18.060.06
+0.36%
Coeur D Alene Bancorp
RGNNF0.65N/A
N/A
RENERGEN LTD

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
+3.17%
SER - LIANY
69%
Closely correlated
-3.26%
GERN - LIANY
53%
Loosely correlated
+2.14%
TRML - LIANY
28%
Poorly correlated
+1.42%
OTLK - LIANY
23%
Poorly correlated
+4.09%
MTNB - LIANY
21%
Poorly correlated
-2.43%
More

SER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been closely correlated with LIANY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SER jumps, then LIANY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-3.26%
LIANY - SER
69%
Closely correlated
+3.17%
GERN - SER
65%
Loosely correlated
+2.14%
XTLB - SER
59%
Loosely correlated
+10.00%
ELVN - SER
37%
Loosely correlated
+0.44%
TOVX - SER
34%
Loosely correlated
-1.56%
More